My Gene Counsel
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Solutions
    • Genetic Counselor Multiplier
    • Living Lab Reports
    • One-Stop Program
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

by Danielle Bonadies | Dec 29, 2020 | Press Releases

With transformative digital technologies playing an increasingly critical role in health care delivery, the two companies have joined forces on a digital genomic solution that will increase efficiencies and outcomes within the highly specialized space of oncology. NEW...
Tumor Testing: Finding the Right Key for Your Lock

Tumor Testing: Finding the Right Key for Your Lock

by Danielle Bonadies | Nov 12, 2020 | Genetic Journal

November is Lung Cancer Awareness Month. According to the Centers for Disease Control and Prevention (CDC), lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States. On top of those jarring...
MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

by Danielle Bonadies | Jul 24, 2020 | News

If the goal is to enroll as many people as possible in a precision medicine program, the process has to be easy for patients, regardless of their condition, geographic location, or socioeconomic situation. That is the aim of the Multiple Myeloma Research...
Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Danielle Bonadies | Jun 26, 2020 | Publications

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

by Danielle Bonadies | Feb 6, 2020 | News

Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
12Next >

Recent Posts

  • Oncology Insights: The Speed and Scope of Genetic Updates Expanding Genetic Testing to Advance Precision Medicine
  • My Gene Counsel and FamGenix Announce Strategic Partnership to Transform Genetic Risk Assessment and Patient Education
  • Genetic Counseling Toolkit For Students
  • 2024 STEM Gift Guide
  • Grant Superhero: Kathleen Valverde, PhD, LCGC

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©